November 13, 2008 - Based on its recent analysis of the drug eluting-stents (DES) market, Frost & Sullivan today ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.Â
November 12, 2008
November 11, 2008 - Global Therapeutics today initiated of the world's first clinical trial of a drug-eluting stent that ...
November 10, 2008October 31, 2008 - Surface modification and drug delivery technologies company SurModics Inc. said today it is providing ...
October 30, 2008Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023October 30, 2008 - Medtronic Inc. said today it plans to launch its portfolio of angioplasty products in the U.S. on the ...
October 30, 2008Boston Scientific's TAXUS Express2 Atom paclitaxel-eluting coronary stent system is a drug-eluting stent (DES) ...
October 30, 2008October 29, 2008 - Nearly 18 months of data from Cappella’s Sideguard I and II self-expanding side branch heart stent in ...
October 29, 2008October 30, 2008 - C. R. Bard Inc. today received approval from the FDA to market the Flair Endovascular Stent ...
October 29, 2008October 30, 2008 - Abbott this week received a 2008 Chicago Innovation Award for its XIENCE V Everolimus Eluting ...
October 29, 2008October 27, 2008 - Boston Scientific Corp. last week said the FDA approved its Carotid WALLSTENT Monorail ...
October 26, 2008October 27, 2008 - Medtronic Inc. last week announced the U.S. market launch of the Talent Thoracic Stent Graft on the ...
October 26, 2008October 21, 2008 - MIV Therapeutics Inc., a developer of coatings and drug-delivery systems for cardiovascular stents ...
October 20, 2008Feature | Dave Fornell
The stent wars continued at the Transcatheter Cardiovascular Therapeutics 2008 20th annual symposium last week with ...
October 20, 2008
The Ostial Pro Stent Positioning System is designed to facilitate precise stent implantation in coronary and renal ...
October 19, 2008October 20, 2008 – At TCT last week Abbott announced two-year data from 30 patients in its ABSORB clinical trial ...
October 19, 2008October 17, 2008 - Boston Scientific Corp. announced results at TCT from an analysis of the HORIZONS-AMI trial showing a ...
October 16, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now